Clinical Trials Sponsored by Alchemia Oncology

Total 4525 results

Hellenic Cooperative Oncology Group

Active, not recruiting

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Breast Cancer

Greece
Que Oncology
Syneos Health

Completed

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Vasomotor Symptoms (VMS)

United States, New Zealand, Australia
Hellenic Cooperative Oncology Group

Completed

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (HeCOG/CDKi)

Breast Cancer Stage IV

Greece
Hellenic Cooperative Oncology Group

Completed

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
Portuguese Oncology Institute, Coimbra

Completed

The Colon Endoscopic Bubble Scale (CEBuS); Validation Study (CEBuS)

Colon Polyp

Portugal
Japanese Gynecologic Oncology Group

Completed

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

Japan
Radiation Therapy Oncology Group

Completed

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Glioma | Astrocytoma | Glioblastoma Multiforme
Celgene
Gynecologic Oncology Group

Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

United States
Hellenic Cooperative Oncology Group

Completed

Corellation of Mutations, TILs and Age in Breast Cancer

Breast Cancer
Hellenic Cooperative Oncology Group

Completed

K-RAS and EGFR in Lung Cancer (K-RAS_NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Unknown

Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment (MINOAS)

Metastatic Colorectal Cancer

Greece
Hellenic Oncology Research Group

Unknown

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Non Small Cell Lung Cancer

Greece
European Institute of Oncology

Terminated

Fenretinide in Healthy Young Women at Genetic and Familial Risk

High-Risk Cancer

Italy
Institute of Oncology Ljubljana

Unknown

Individual Approach in Gynecological Cancer Brachytherapy

Cancer

Slovenia
European Institute of Oncology

Terminated

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

Melanoma

Italy
Translational Oncology Research International

Completed

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
Prostate Oncology Specialists, Inc.

Completed

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Prostate Cancer | Castrate Resistant Prostate Cancer

United States
Hellenic Oncology Research Group

Completed

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Ovarian Cancer

Greece
European Institute of Oncology

Completed

Early Smoking Reduction or Cessation by Means of no Nicotine Electronic Cigarette Added to Standard Counselling.

Myocardial Infarction | Cancer

Italy
US Oncology Research
Pfizer

Completed

Gemzar, Cisp, Sunitinib Urothelial Ca

Urothelial Cancer

United States
Hellenic Oncology Research Group

Completed

Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Translational Research in Oncology

Completed

Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Translational Research in Oncology

Terminated

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Ovarian Neoplasms

United States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
Hellenic Oncology Research Group

Terminated

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group

Terminated

Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer

Gastric Cancer

Greece
Hellenic Oncology Research Group

Completed

Pazopanib in Relapsed and Refractory Small Cell Lung Cancer

SCLC

Greece
Hellenic Oncology Research Group

Completed

Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
Hellenic Oncology Research Group

Terminated

Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC

NSCLC

Greece
Vector Oncology
Eisai Inc.

Terminated

Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer

HER-2 Positive Breast Cancer

United States
Korean Gynecologic Oncology Group

Unknown

Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study

Endometrial Hyperplasia

Korea, Republic of
Hellenic Cooperative Oncology Group

Completed

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Breast Tumors | Brain Metastases | Lung Tumors

Greece
Hellenic Oncology Research Group

Completed

Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

Metastatic Colorectal Cancer

Greece
Texas Oncology Cancer Center

Terminated

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Multiple Myeloma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Aplastic Anemia | Non-Hodgkins Lymphoma | Hodgkins Disease

United States
Korean Gynecologic Oncology Group

Unknown

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

Korea, Republic of
Institute of Oncology Ljubljana

Unknown

Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer

Rectal Cancer

Slovenia
Tokyo Metropolitan Oncology Group

Unknown

Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients (TMOG-GC01)

Gastric Cancer

Japan
Hellenic Cooperative Oncology Group

Terminated

Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) (HIT)

Metastatic Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Terminated

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)

Advanced Non-Small Cell Lung Cancer

Greece
Maastricht Radiation Oncology
Pfizer

Completed

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Non Small Cell Lung Carcinoma

Netherlands
Geriatric Oncology Consortium
Sanofi

Completed

Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Geriatric Oncology Consortium
Sanofi

Terminated

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Breast Cancer | Lung Cancer

United States
Korean Gynecologic Oncology Group

Unknown

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients

Endometrial Cancer

Korea, Republic of
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

Melanoma (Skin)
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Chondrosarcoma | Adult Rhabdomyosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma | Adult Malignant Meningioma | Adult Brain Malignant Hemangiopericytoma

United States, Australia, Peru, Puerto Rico
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; Southwest Oncology Group

Completed

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage... and other conditions

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Adult Meningioma

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Withdrawn

S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx

Head and Neck Cancer
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; Southwest Oncology Group

Completed

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Prostate Cancer

United States, South Africa
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Withdrawn

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States

Clinical Trials Sponsored by Alchemia Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations